Cite
HARVARD Citation
Lythgoe, M. et al. (2021). How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond. European journal of cancer. pp. 68-70. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lythgoe, M. et al. (2021). How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond. European journal of cancer. pp. 68-70. [Online].